1

How to avoid another 'Vioxx'

Year:
2005
Language:
english
File:
PDF, 158 KB
english, 2005
3

Pharma companies becoming more aggressive towards generics firms

Year:
2006
Language:
english
File:
PDF, 882 KB
english, 2006
6

New neglected disease research scheme pools IP and expertise

Year:
2012
Language:
english
File:
PDF, 77 KB
english, 2012
16

10.1038/35089548

Year:
2001
Language:
english
File:
PDF, 386 KB
english, 2001
17

10.1038/35089546

Year:
2001
Language:
english
File:
PDF, 583 KB
english, 2001
18

Stem cell funding suspended

Year:
2001
Language:
english
File:
PDF, 500 KB
english, 2001
19

10.1038/35099048

Year:
2001
Language:
english
File:
PDF, 151 KB
english, 2001
20

10.1038/35099046

Year:
2001
Language:
english
File:
PDF, 373 KB
english, 2001
21

Damage control

Year:
2001
Language:
english
File:
PDF, 282 KB
english, 2001
22

BSE blunder

Year:
2001
Language:
english
File:
PDF, 347 KB
english, 2001
23

Role model

Year:
2001
Language:
english
File:
PDF, 572 KB
english, 2001
24

The final research frontier?

Year:
2001
Language:
english
File:
PDF, 246 KB
english, 2001
25

Drug safety special: Chasing shadows

Year:
2005
Language:
english
File:
PDF, 535 KB
english, 2005
26

Drug discovery: Playing dirty

Year:
2005
Language:
english
File:
PDF, 940 KB
english, 2005
27

Changing attitudes in the world of drug discovery

Year:
2003
Language:
english
File:
PDF, 233 KB
english, 2003
28

Professor still missing

Year:
2002
Language:
english
File:
PDF, 52 KB
english, 2002
29

Set back to Alzheimer vaccine studies

Year:
2002
Language:
english
File:
PDF, 1.00 MB
english, 2002
30

Heartbeat clue to diagnosing vCJD

Year:
2002
Language:
english
File:
PDF, 259 KB
english, 2002
31

10.1038/nm1201-1261b

Year:
2001
Language:
english
File:
PDF, 25 KB
english, 2001
32

Therapeutics: Overcoming inhibition

Year:
2004
Language:
english
File:
PDF, 170 KB
english, 2004
33

From the analyst's couch: New drug approvals for 2002

Year:
2003
Language:
english
File:
PDF, 169 KB
english, 2003
34

Creating the right chemistry

Year:
2003
Language:
english
File:
PDF, 49 KB
english, 2003
35

RNA-targeted drugs: The Essence of correction

Year:
2003
Language:
english
File:
PDF, 319 KB
english, 2003
36

Cancer: Parc keeper

Year:
2003
Language:
english
File:
PDF, 192 KB
english, 2003
37

Screening the right candidate

Year:
2003
Language:
english
File:
PDF, 80 KB
english, 2003
38

In vivo we trust

Year:
2003
Language:
english
File:
PDF, 86 KB
english, 2003
39

Analytical jobs for analytical minds

Year:
2003
Language:
english
File:
PDF, 79 KB
english, 2003
40

Better antibiotics through chemistry

Year:
2004
Language:
english
File:
PDF, 135 KB
english, 2004
41

Does size really matter?

Year:
2003
Language:
english
File:
PDF, 68 KB
english, 2003
42

Innovation through integration

Year:
2003
Language:
english
File:
PDF, 40 KB
english, 2003
43

Fresh from the pipeline: Bortezomib

Year:
2003
Language:
english
File:
PDF, 900 KB
english, 2003
44

The drug approval tactician

Year:
2003
Language:
english
File:
PDF, 51 KB
english, 2003
45

Choosing a career in private or corporate patent practice

Year:
2003
Language:
english
File:
PDF, 38 KB
english, 2003
46

Pursuing a career in medical sales

Year:
2004
Language:
english
File:
PDF, 43 KB
english, 2004
47

High-Throughput Screening: Screen test

Year:
2003
Language:
english
File:
PDF, 162 KB
english, 2003
48

Why are clinical costs so high?

Year:
2003
Language:
english
File:
PDF, 85 KB
english, 2003
49

Antidepressant use in children questioned

Year:
2003
Language:
english
File:
PDF, 104 KB
english, 2003
50

The FDA needs you

Year:
2004
Language:
english
File:
PDF, 49 KB
english, 2004